Mealey's (August 27, 2019, 12:37 PM EDT) -- ALEXANDRIA, Va. — In an Aug. 26 filing, Bio-Rad Laboratories Inc. tells the Patent Trial and Appeal Board that its patent claims directed to “novel and advanced” polymerase chain reaction thermal cycling instruments with integrated optics represent “the first such system in the field” and should not be canceled (Agilent Technologies Inc. v. Bio-Rad Laboratories Inc., No. IPR2019-00271, PTAB)....